Union Pharmacist results, Q2 2025
Net profit, assets, equity and cash flow for Q2 2025, against the same period a year earlier, from the published financial statements.
Net profit-306 thousandEGP · −24.8% vs the same period a year earlier
Total assets84.86 millionEGP · +48.5% vs the same period a year earlier
Shareholders' equity69.39 millionEGP · +604.4% vs the same period a year earlier
Operating cash flow-82.08 thousandEGP · +29.0% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q2 2025 was about -306 thousand EGP, down −24.8% from -245 thousand EGP in Q2 2024.
- Total assets at the end of Q2 2025 were about 84.86 million EGP, and shareholders' equity about 69.39 million EGP.
- Operating cash flow for Q2 2025 was negative at 82.08 thousand EGP.
Key lines against the same period a year earlier
This periodQ2 2024Change
Net profit-306 thousand-245 thousand−24.8%
Gross profit—52.65 thousand—
Total assets84.86 million57.13 million+48.5%
Total liabilities15.47 million47.28 million−67.3%
Shareholders' equity69.39 million9.85 million+604.4%
Total liabilities and equity84.86 million57.13 million+48.5%
Operating cash flow-82.08 thousand-116 thousand+29.0%
Investing cash flow0-21 thousand+100.0%
Net change in cash-82.08 thousand-137 thousand+39.9%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy